Evaluation of Treatment Satisfaction and KarXT Utilization Registry (RESKU)

Recruiting now

Conditions studied: Schizophrenia

In brief

The purpose of this study is to understand treatment preference and satisfaction among adults with schizophrenia in the United States who are prescribed xanomeline and trospium chloride (X/T) therapy

Key facts

Study ID

NCT07101094

Run by

Bristol-Myers Squibb

People needed

300

Starts

2025-09-22

Expected to finish

2029-05-14

Last updated by the study team

2026-07-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Aged ≥18 years at index date.
• Have a confirmed diagnosis of schizophrenia before index date.
• Receipt of an initial prescription order for xanomeline and trospium chloride (XT) and plan to fill and initiate such therapy.
• Provide a signed and dated Institutional Review Board (IRB)/Independent Ethics Committee (IEC)-approved written informed consent form (ICF) in accordance with regulatory, local, and institutional guidelines.
• Agree to use an electronic device to record, or provide paper entry of, patient-reported outcomes (in English or Spanish).
• English or Spanish speaking.

You may not qualify if…

• Participation in an interventional study within the last 30 days or plan to participate in such study at the time of eligibility screening.
• Evidence of use of XT prior to time of eligibility screening.

Where it is running

• C-Trilogy Outreach — Longview, Texas, United States (enrolling)
• Lumos Clinical Research Center — San Jose, California, United States (enrolling)
• Evanston Hospital — Evanston, Illinois, United States (enrolling)
• The Johns Hopkins Hospital — Baltimore, Maryland, United States (enrolling)
• New Dimension Group — Rose Hill, North Carolina, United States (enrolling)
• Westlake Brain Health — Westlake, Ohio, United States (enrolling)
• Continuum Health Providers — Fort Mill, South Carolina, United States (enrolling)
• Haracec Clinical Research — El Paso, Texas, United States (enrolling)
• Boston Medical Center — Boston, Massachusetts, United States (enrolling)
• Mayflower Clinical — South Dartmouth, Massachusetts, United States (enrolling)
• Omaha Insomnia and Psychiatric Services — Omaha, Nebraska, United States (enrolling)
• Hackensack Meridian Health - Carrier Clinic — Belle Mead, New Jersey, United States (enrolling)
• Radial - Manhattan — New York, New York, United States (enrolling)
• New Dawn Psychiatric Services, PLLC — Kinston, North Carolina, United States (enrolling)
• Local Institution - 0017 — Bel Air, Maryland, United States
• Local Institution - 0004 — Catonsville, Maryland, United States
• Local Institution - 0008 — Belmont, Massachusetts, United States
• Local Institution - 0009 — Orange, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.